Compositions, gels and foams with rheology modulators and uses thereof
First Claim
Patent Images
1. A therapeutic composition comprising:
- a first rheology modulator comprising a pharmaceutical or a cosmetic active agent at least part of which is suspended in the therapeutic composition; and
a carrier comprising;
a) a second rheology modulator selected from the group consisting of (i) a combination of at least one fatty alcohol and at least one wax;
(ii) a combination of at least one fatty acid and at least one wax; and
(iii) a combination of;
at least one fatty alcohol, at least one fatty acid, and at least one wax; and
b) at least one hydrophobic solvent;
the carrier being otherwise free of or containing less than 0.1% by weight of surfactant;
wherein the at least one wax comprises a hydrogenated castor oil;
wherein the viscosity of the therapeutic composition is at least about 30% higher than the viscosity of a first partial composition comprising the carrier without the first rheology modulator; and
is higher than the viscosity of the first rheology modulator and the at least one hydrophobic solvent without the second rheology modulator; and
wherein the viscosity of the first partial composition is less than about 25,000 cPs at room temperature.
11 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure relates generally to compositions for cosmetic or pharmaceutical application. The compositions include a carrier and rheology modulators.
-
Citations
25 Claims
-
1. A therapeutic composition comprising:
-
a first rheology modulator comprising a pharmaceutical or a cosmetic active agent at least part of which is suspended in the therapeutic composition; and a carrier comprising; a) a second rheology modulator selected from the group consisting of (i) a combination of at least one fatty alcohol and at least one wax;
(ii) a combination of at least one fatty acid and at least one wax; and
(iii) a combination of;
at least one fatty alcohol, at least one fatty acid, and at least one wax; andb) at least one hydrophobic solvent; the carrier being otherwise free of or containing less than 0.1% by weight of surfactant; wherein the at least one wax comprises a hydrogenated castor oil; wherein the viscosity of the therapeutic composition is at least about 30% higher than the viscosity of a first partial composition comprising the carrier without the first rheology modulator; and
is higher than the viscosity of the first rheology modulator and the at least one hydrophobic solvent without the second rheology modulator; andwherein the viscosity of the first partial composition is less than about 25,000 cPs at room temperature. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25)
-
Specification